Legend Biotech Corporation (LEGN) Total Assets by Year
Legend Biotech Corporation closed fiscal year 2025 with $1.7B in total assets, $731.6M in total liabilities and $1.0B in shareholder equity. This represents an increase of 3.8% from the prior fiscal year. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Legend Biotech Corporation has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
LEGN Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2520-F | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.7B+3.8% | $1.7B-9.7% | $1.8B+38.9% | $1.3B+18.9% | $1.1B+55.0% | $722.1M+151.0% | $287.7M | N/A |
| Total Liabilities | $731.6M+16.2% | $629.6M+5.4% | $597.2M+1.8% | $586.7M+65.9% | $353.5M+184.4% | $124.3M-8.8% | $136.4M | N/A |
| Total Equity | $1.0B-3.7% | $1.0B-16.8% | $1.3B+68.1% | $744.4M-2.8% | $765.9M+28.1% | $597.8M+295.0% | $151.3M-40.2% | $252.9M |
LEGN Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q4'2520-F | Q3'256-K | Q2'256-K | Q1'2510-Q | Q4'2420-F | Q3'246-K | Q2'246-K | Q1'2410-Q | Q4'2310-K | Q3'2310-Q | Q2'2310-Q | Q1'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.7B+3.8% | $1.7B-1.3% | $1.7B-6.0% | $1.6B-9.0% | $1.7B-9.7% | $1.7B-5.6% | $1.8B-6.9% | $1.8B | $1.8B+38.9% | $1.8B | $1.9B | N/A |
| Total Liabilities | $731.6M+16.2% | $701.7M+13.2% | $654.4M+2.4% | $597.9M-2.2% | $629.6M+5.4% | $619.7M+24.0% | $639.2M+22.1% | $611.0M | $597.2M+1.8% | $499.7M | $523.6M | N/A |
| Total Equity | $1.0B-3.7% | $1.0B-9.4% | $1.0B-10.7% | $1.0B-12.6% | $1.0B-16.8% | $1.1B-16.7% | $1.2B-17.6% | $1.2B+78.2% | $1.3B+68.1% | $1.3B+55.4% | $1.4B+150.1% | $653.2M |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Legend Biotech Corporation financials
Frequently Asked Questions
What was Legend Biotech Corporation's total assets in fiscal year 2025?
Legend Biotech Corporation closed fiscal year 2025 with $1.7B in total assets, $731.6M in total liabilities and $1.0B in shareholder equity.
How fast is Legend Biotech Corporation's total assets growing?
Legend Biotech Corporation (LEGN) total assets rose by 3.8% year over year, from $1.7B to $1.7B in fiscal year 2025.
What was Legend Biotech Corporation's total assets in the most recent quarter?
Legend Biotech Corporation (LEGN) reported $1.7B in total assets in Q4 2025. This represents an increase of 3.8% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Legend Biotech Corporation (LEGN) reported on that line in every period on record.